Stock Price Quote

INDRAPRASTHA MEDICAL CORPORATION LTD.

NSE : INDRAMEDCOBSE : 532150ISIN CODE : INE681B01017Industry : Hospital & Healthcare ServicesHouse : Apollo Hospitals
BSE171.757.75 (+4.73 %)
PREV CLOSE ( ) 164.00
OPEN PRICE ( ) 164.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 65456
TODAY'S LOW / HIGH ( )164.00 172.20
52 WK LOW / HIGH ( )76.08 230
NSE171.358.15 (+4.99 %)
PREV CLOSE( ) 163.20
OPEN PRICE ( ) 163.05
BID PRICE (QTY) 171.35 (5000)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 138150
TODAY'S LOW / HIGH( ) 163.05 171.35
52 WK LOW / HIGH ( )76.1 229.8
1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 16-03 1988
Management Info
- Chairman P Shivakumar - Managing Director
Registered Office

Address Sarita Vihar,Delhi - Mathura Road,,
New Delhi,
Delhi-110076

Phone 011- 26925858 / 26925801

Email imcl@apollohospitals.com

Website www.apollohospdelhi.com

Registrars Details
Link Intime India Pvt Ltd.
Noble Heights, 1st Floor, Plot NH 2,C-1 Block LSC, Near Savitri Market,Janakpuri,New Delhi
Listing : BSE, NSE, MCX

NEWS

23Mar Indraprastha Medical Corporation infor
Pursuant to the provisions of the Code of Conduct for Prevention of Insi..
23Mar Indraprastha Medical Corporation infor
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosur..
07Mar Appointment of Director
Inter-alia, considered and appointed Mr. Tejpreet Singh Chopra (DIN 0005..
05Mar Appointment of Director
Inter alia, to consider and approve the appointment of an Independent Di..
05Mar Indraprastha Medical Corporation infor
Pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosur..

Financials

in Millions
QTR Dec 23 ANNUAL 23
Net Profit294.4861.499999999999
Gross Profit 406.7 1171.8
Operating Profit 515.71607.3
Net Sales 3064.610986.7

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Apollo Hospital Ent. (BSE)
peergroup  6351.90 (1.95%)
M.Cap ( in Cr)91330.58
Kovai Medical Center (BSE)
peergroup  3741.85 (2.49%)
M.Cap ( in Cr)4094.43
RainbowChildrenS Med (BSE)
peergroup  1298.00 (4.01%)
M.Cap ( in Cr)13174.92
Thyrocare Tech. (BSE)
peergroup  592.20 (5.48%)
M.Cap ( in Cr)3135.86
Max Healthcare Inst (BSE)
peergroup  820.40 (2.08%)
M.Cap ( in Cr)79735.69

Shareholding Pattern

FI/BANKS/INSURANCE 6.36%
PROMOTERS 51%
NON-INSTITUTION 41.68%
MUTUAL FUNDS/UTI 0%
GOVERNMENT 0%
FII 0%

About Indraprastha Medical Corporation Ltd.

Indraprastha Medical Corporation Ltd. was incorporated in the year 1988. Its today's share price is 171.75. Its current market capitalisation stands at Rs 1574.48 Cr. In the latest quarter, company has reported Gross Sales of Rs. 10986.7 Cr and Total Income of Rs.11087 Cr. The company's management includes P Shivakumar, Suneeta Reddy, Vineeta Rai, Vinayak Chatterjee, Vikram Bhat, Sangita Reddy, S Regunathan, Satnam Arora, Salil Singhal, Menaka Guruswami, Mahesh Verma, Madhumita Ganguli, Deepak Vaidya, Arun Rai, Prathap C Reddy, Priya Ranjan.

It is listed on the BSE with a BSE Code of 532150 , NSE with an NSE Symbol of INDRAMEDCO and ISIN of INE681B01017. It's Registered office is at Sarita Vihar,Delhi - Mathura Road,New Delhi-110076, Delhi. Their Registrars are K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.) It's auditors are SC Vasudeva & Co, SN Dhawan & Co LLP

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.